Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glucosyltransferase B (GtfB) is an extracellular enzyme secreted by the cariogenic bacterium Streptococcus mutans, which plays a pivotal role in the pathogenesis of dental caries. GtfB catalyzes the cleavage of dietary sucrose to synthesize water-insoluble glucans (primarily containing alpha-1,3-glucosidic linkages) that form the structural scaffold of the dental plaque biofilm. This insoluble extracellular polysaccharide matrix promotes the adherence and accumulation of S. mutans and other acidogenic microorganisms on the tooth surface, creating a protected, acidic microenvironment that leads to enamel demineralization. GtfB also mediates cross-kingdom interactions by binding to the cell wall mannans of Candida albicans, further enhancing biofilm stability and virulence. As a therapeutic target, GtfB is highly attractive because inhibiting its activity impairs biofilm formation and bacterial virulence without killing the bacteria, thereby minimizing selective pressure for drug resistance and preserving the commensal oral microbiota. Various natural polyphenols (such as apigenin and epigallocatechin gallate), small-molecule inhibitors (like G43), and repurposed drugs (such as radotinib and pranlukast) are being investigated for their ability to target GtfB and prevent dental caries.
Inhibition of glucosyltransferase enzymatic activity to prevent the synthesis of water-insoluble glucans and disrupt biofilm formation.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucosyltransferase B (GtfB).